Analystreport

Kazia Therapeutics Limited (NASDAQ: KZIA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com